Putney Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-220
Closed -$5.33K 222
2025
Q2
$5.33K Buy
+220
New +$5.13K 0.01% 247
2025
Q1
Sell
-584
Closed -$15.5K 305
2024
Q4
$15.5K Buy
+584
New +$15.8K 0.01% 189

Other funds holding PFE

Putney Financial Group's PFE Position: Q3 2025 in Review

Putney Financial Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 220 shares — an estimated $5.33K sold.

Putney Financial Group first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $15.5K in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Putney Financial Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Putney Financial Group sold 220 Pfizer shares in Q3 2025, an estimated $5.33K.
  • Putney Financial Group first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Putney Financial Group's Pfizer position peaked at $15.5K in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Putney Financial Group's 13F filing for Q3 2025, filed 7 Nov 2025.